Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0270 Transporter Info
Gene Name SLC30A10
Transporter Name Zinc transporter 10
Gene ID
55532
UniProt ID
Q6XR72

Transcriptional Regulation of This DT (TSR)

TF Superclass 1: Basic domains

      Class 1.1: Basic leucine zipper factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        ATF4 

Click to Show/Hide to Show 2 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in neurodegenerative diseases condition [1]

TF Protein Name

 Cyclic AMP-dependent transcription factor ATF-4 Transcription Factor Info

Affected Drug/Substrate

 Manganese

Studied Phenotype

 Neurodegenerative diseases [ICD11: 8A20-8A2Z]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6N mice

Detailed Description

 Cyclic AMP-dependent transcription factor ATF-4 (ATF4) has been reported to activate the transcription of SLC30A10 gene in neurodegenerative diseases condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

       Transcriptional Phenomenon 2

 Activation of SLC30A10 gene in health condition [1]

TF Protein Name

 Cyclic AMP-dependent transcription factor ATF-4 Transcription Factor Info

Studied Phenotype

 Heallth [ICD11: N.A]

Tissue

 Brain

Related DT Changes

 up regulating

Experimental Material

 C57BL/6N mice

Detailed Description

 Cyclic AMP-dependent transcription factor ATF-4 (ATF4), influenced by the exogenous 1-methyl-4-phenylpyridinium, has been reported to activate the transcription of SLC30A10 gene in health condition , which leads to an increased expression of the drug transporter Zinc transporter 10.

      Class 1.2: Basic helix-loop-helix factors

Click to Show/Hide the Full List of 5 TF(s) Regulating This DT

        AHR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC30A10 gene in hepatoblastoma condition [2]

TF Protein Name

 Aryl hydrocarbon receptor Transcription Factor Info

Affected Drug/Substrate

 Zinc

Studied Phenotype

 Hepatoblastoma [ICD11: 2C12.01]

Tissue

 Liver

Related DT Changes

 down regulating

Experimental Material

 Human hepatoblastoma cells (HepG2)

Detailed Description

 Aryl hydrocarbon receptor (AHR), influenced by the exogenous beta-naphthoflavone, has been reported to repress the transcription of SLC30A10 gene in hepatoblastoma condition , which leads to a decreased expression of the drug transporter Zinc transporter 10.

        ARNT 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in manganese excess condition [3]

TF Protein Name

 Aryl hydrocarbon receptor nuclear translocator Transcription Factor Info

Affected Drug/Substrate

 Manganese

Studied Phenotype

 Manganese excess [ICD11: 5B91.5]

Tissue

 Small intestine

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6J mice

Detailed Description

 Aryl hydrocarbon receptor nuclear translocator (ARNT) has been reported to activate the transcription of SLC30A10 gene in manganese excess condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

        ARNT2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in manganese excess condition [3]

TF Protein Name

 Aryl hydrocarbon receptor nuclear translocator 2 Transcription Factor Info

Affected Drug/Substrate

 Manganese

Studied Phenotype

 Manganese excess [ICD11: 5B91.5]

Tissue

 Small intestine

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6J mice

Detailed Description

 Aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) has been reported to activate the transcription of SLC30A10 gene in manganese excess condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

        EPAS1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in manganese excess condition [3]

TF Protein Name

 Endothelial PAS domain-containing protein 1 Transcription Factor Info

Affected Drug/Substrate

 Manganese

Studied Phenotype

 Manganese excess [ICD11: 5B91.5]

Tissue

 Small intestine

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6J mice

Detailed Description

 Endothelial PAS domain-containing protein 1 (EPAS1) has been reported to activate the transcription of SLC30A10 gene in manganese excess condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

        HIF1A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in manganese excess condition [3]

TF Protein Name

 Hypoxia-inducible factor 1-alpha Transcription Factor Info

Affected Drug/Substrate

 Manganese

Studied Phenotype

 Manganese excess [ICD11: 5B91.5]

Tissue

 Small intestine

Related DT Changes

 Up regulating

Experimental Material

 C57BL/6J mice

Detailed Description

 Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC30A10 gene in manganese excess condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        VDR 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in colon cancer condition [4]

TF Protein Name

 Vitamin D3 receptor Transcription Factor Info

Studied Phenotype

 Colon cancer [ICD11: 2B90]

Tissue

 Colon

Related DT Changes

 Up regulating

Experimental Material

 Human colon adenocarcinoma cells (Caco-2)

Detailed Description

 Vitamin D3 receptor (VDR) has been reported to activate the transcription of SLC30A10 gene in colon cancer condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        HNF1B 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC30A10 gene in renal cysts condition [5]

TF Protein Name

 Hepatocyte nuclear factor 1-beta Transcription Factor Info

Studied Phenotype

 Renal cysts [ICD11: GB80]

Tissue

 Kidney

Related DT Changes

 Up regulating

Experimental Material

 Zebrafish TgPT::EGFP)

Detailed Description

 Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC30A10 gene in renal cysts condition, which leads to an increased expression of the drug transporter Zinc transporter 10.

        HOXB13 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC30A10 gene [6]

TF Protein Name

 Homeobox protein Hox-B13 Transcription Factor Info

Tissue

 Colon; Prostate

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Homeobox protein Hox-B13 (HOXB13) can directly bind to the SLC30A10 gene, which in turn affects the expression or function of the drug transporter Zinc transporter 10.

      Class 3.3: Fork head / winged helix factors

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        FOXA1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Direct binding to SLC30A10 gene [7]

TF Protein Name

 Hepatocyte nuclear factor 3-alpha Transcription Factor Info

Tissue

 Breast; Embryo; Liver; Lung; Prostate

Related DT Changes

 Direct regulating

Experiment method

 TF-transporter regulations were collected from ChIP-Seq datasets.

Detailed Description

 Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC30A10 gene, which in turn affects the expression or function of the drug transporter Zinc transporter 10.
References
1 Protective function of SLC30A10 induced via PERK-ATF4 pathway against 1-methyl-4-phenylpyridinium. Biochem Biophys Res Commun. 2017 Sep 2;490(4):1307-1313.
2 beta-Naphthoflavone, an exogenous ligand of aryl hydrocarbon receptor, disrupts zinc homeostasis in human hepatoma HepG2 cells. J Toxicol Sci. 2019;44(10):711-720.
3 Up-regulation of the manganese transporter SLC30A10 by hypoxia-inducible factors defines a homeostatic response to manganese toxicity. Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):e2107673118.
4 Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor. J Steroid Biochem Mol Biol. 2016 Oct;163:77-87.
5 Transcriptional profiling of the zebrafish proximal tubule. Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F478-F488.
6 NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(D1):D991-5.
7 hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets. Genomics Proteomics Bioinformatics. 2020 Apr;18(2):120-439. (ID:ENSG00000196660)

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.